EVA MARÍA
CIRUELOS GIL
Profesora asociada de Ciencias de la Salud
Université Catholique de Louvain
Louvain-la-Neuve, BélgicaPublicaciones en colaboración con investigadores/as de Université Catholique de Louvain (2)
2020
-
Standard anthracycline based versus docetaxel-capecitabine in early high clinical and/or genomic risk breast cancer in the EORTC 10041/BIG 3-04 MINDACT phase III trial
Journal of Clinical Oncology, Vol. 38, Núm. 11, pp. 1186-1197
2019
-
Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
The Lancet Oncology, Vol. 20, Núm. 9, pp. 1226-1238